• Nenhum resultado encontrado

Rev. Bras. Hematol. Hemoter. vol.33 número1

N/A
N/A
Protected

Academic year: 2018

Share "Rev. Bras. Hematol. Hemoter. vol.33 número1"

Copied!
1
0
0

Texto

(1)

Rev Bras Hematol Hemoter. 2011;33(1) 85

Santiago Pavlovsky

Memorial Lecture

A tireless worker, he promoted clinical research in Argentina and was well aware of how to accomplish and transmit warmth in medical treatment and excellence in scientific production to his disciples.

Born into a family of outstanding hematologists, Santiago graduated as a Medical Doctor at the University of Buenos Aires in 1964, and completed his postgraduate degree at the Hospital Saint Louis of Paris with Professor Jean Bernard.

Once he returned to Argentina, after working at the Instituto de Investigaciones Hematológicas, Academia Nacional de Medicina, he created the GATLA, Argentine Group for the treatment of Acute Leukemia, a pioneering group in clinical research in Latin America, through which he made innovative worldwide contributions about Hodgkin's disease; improving care of patients in our country through the creation of treatment protocols.

From 1983 to 1986, he coordinated from Washington the Collaborative Cancer Treatment Research Program of the National Cancer Institute and the Pan American Health Organization.

He was a Coordinator of International Affairs for the American Society of Clinical Oncology (ASCO) and the European School of Oncology.

Since 1989, he was the medical director of Fundación para Combatir la Leucemia (Fundaleu), and then the scientific director.

Doctor Pavlovsky was an outstanding scientist, who was a member of the most important medical societies of his specialty in the world.

He published 144 scientific papers and 76 book chapters. He was "Physician of the Year" in 2000.

Disregarding his high academic level, he always managed to be not only side by side with his patients at his practice or through hospitalization, relieving and curing them, but also with his colleagues and disciples, encouraging them to continuously surpass the struggle against malignant hemopathies.

He died last September 19th. The Argentinean hematological community will always

remember him as one of the special figures in the development of the specialty.

Submitted: 12/27/2010 Accepted: 12/28/2010

Correspondence: Jorge H. Milone Sociedad Argentina de Hematología Julian Alvarez 146 – Ciudad Autónoma de BS As – Argentina

Phone: 54 11 4855 2452/2485 [email protected]

www.rbhh.org or www.scielo.br/rbhh

DOI: 10.5581/1516-8484.20110021

xxx President, Sociedad Argentina de

Hematología

Referências

Documentos relacionados

Conclusion: Autologous hematopoietic stem cell transplantation is an effective treatment strategy for early and late relapse in classical Hodgkin's lymphoma for cases that

Methods: A questionnaire was mailed to 36 Brazilian transplant centers with questions about basic oral care protocols, the indication of specific mouthwashes, antibiotic

The aim of the present study was to evaluate allele polymorphisms of the Rh, Kell, Duffy and Kidd blood group systems in a population from the northwestern region of the State

Conclusion: The baseline blood lactate of SS and SC individuals is 3 to 4 times higher than that of healthy subjects, probably due to the fact that these patients have a

Figure 1 – Treatment of MDS, with the probabilities, percentage of response, treatment used and total cost for all patients for each pathway over one year according to this model..

Keywords: Immunophenotyping; Flow cytometry; Paroxysmal nocturnal hemoglobinuria; Diagnosis; Antigen, CD55; Antigen,

Thus the objective of this study was to estimate the prevalence of HBV infection, and to analyze the factors associated with HBV infection, in a population of first-time blood donors

To evaluate the coverage of studies, the publication sample size was compared with the number of live births in the region in the study period using data from the Live Birth